GT200600235A - Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactamasas clase d - Google Patents
Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactamasas clase dInfo
- Publication number
- GT200600235A GT200600235A GT200600235A GT200600235A GT200600235A GT 200600235 A GT200600235 A GT 200600235A GT 200600235 A GT200600235 A GT 200600235A GT 200600235 A GT200600235 A GT 200600235A GT 200600235 A GT200600235 A GT 200600235A
- Authority
- GT
- Guatemala
- Prior art keywords
- beta
- class
- penemes
- inhibitors
- hydrogenic
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108020004256 Beta-lactamase Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000006635 beta-lactamase Human genes 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68622105P | 2005-06-01 | 2005-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200600235A true GT200600235A (es) | 2007-03-29 |
Family
ID=37836305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200600235A GT200600235A (es) | 2005-06-01 | 2006-06-01 | Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactamasas clase d |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060276446A1 (enExample) |
| EP (1) | EP1885358A2 (enExample) |
| JP (1) | JP2008542376A (enExample) |
| CN (1) | CN101189010A (enExample) |
| AR (1) | AR054467A1 (enExample) |
| AU (1) | AU2006287938A1 (enExample) |
| BR (1) | BRPI0611491A2 (enExample) |
| CA (1) | CA2610478A1 (enExample) |
| GT (1) | GT200600235A (enExample) |
| MX (1) | MX2007015173A (enExample) |
| PE (1) | PE20070010A1 (enExample) |
| SV (1) | SV2007002555A (enExample) |
| TW (1) | TW200716104A (enExample) |
| WO (1) | WO2007030166A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| TW200716102A (en) * | 2005-06-01 | 2007-05-01 | Wyeth Corp | Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors |
| US8512789B2 (en) * | 2005-11-23 | 2013-08-20 | The Coca-Cola Company | High-potency sweetener composition with dietary fiber and compositions sweetened therewith |
| US8945652B2 (en) | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
| US8524304B2 (en) | 2005-11-23 | 2013-09-03 | The Coca-Cola Company | High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith |
| JP2012121809A (ja) * | 2009-02-26 | 2012-06-28 | Eisai R & D Management Co Ltd | 多環式化合物の製造法およびその中間体 |
| US20110288063A1 (en) * | 2010-05-19 | 2011-11-24 | Naeja Pharmaceutical Inc. | Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors |
| CN104341345B (zh) * | 2014-10-24 | 2016-03-23 | 海门海康生物医药科技有限公司 | 一种2-甲氧基-6-酮-5,6,7,8-四氢喹啉的合成方法 |
| US12240855B2 (en) | 2019-03-06 | 2025-03-04 | Daiichi Sankyo Company, Limited | Pyrrolopyrazole derivative |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ286898B6 (en) * | 1994-04-25 | 2000-07-12 | Smithkline Beecham Plc | Pharmaceutical preparation |
| US20040132706A1 (en) * | 2001-10-05 | 2004-07-08 | Daniela Salvemini | Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| US20040132708A1 (en) * | 2002-05-01 | 2004-07-08 | Wyeth | Process for preparing 6-alkylidene penem derivatives |
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039476A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | Proceso para preparar derivados de 6-alquiliden penem |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| TW200716102A (en) * | 2005-06-01 | 2007-05-01 | Wyeth Corp | Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors |
-
2006
- 2006-05-22 TW TW095118171A patent/TW200716104A/zh unknown
- 2006-05-25 CA CA002610478A patent/CA2610478A1/en not_active Abandoned
- 2006-05-25 EP EP06824758A patent/EP1885358A2/en not_active Withdrawn
- 2006-05-25 JP JP2008514712A patent/JP2008542376A/ja not_active Withdrawn
- 2006-05-25 CN CNA2006800193154A patent/CN101189010A/zh active Pending
- 2006-05-25 AU AU2006287938A patent/AU2006287938A1/en not_active Abandoned
- 2006-05-25 MX MX2007015173A patent/MX2007015173A/es unknown
- 2006-05-25 BR BRPI0611491-1A patent/BRPI0611491A2/pt not_active IP Right Cessation
- 2006-05-25 WO PCT/US2006/020410 patent/WO2007030166A2/en not_active Ceased
- 2006-05-31 US US11/444,346 patent/US20060276446A1/en not_active Abandoned
- 2006-05-31 SV SV2006002555A patent/SV2007002555A/es unknown
- 2006-05-31 PE PE2006000563A patent/PE20070010A1/es not_active Application Discontinuation
- 2006-06-01 AR ARP060102292A patent/AR054467A1/es unknown
- 2006-06-01 GT GT200600235A patent/GT200600235A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007015173A (es) | 2008-02-15 |
| CN101189010A (zh) | 2008-05-28 |
| SV2007002555A (es) | 2007-02-02 |
| JP2008542376A (ja) | 2008-11-27 |
| US20060276446A1 (en) | 2006-12-07 |
| WO2007030166A3 (en) | 2007-05-24 |
| CA2610478A1 (en) | 2007-03-15 |
| WO2007030166A2 (en) | 2007-03-15 |
| AU2006287938A1 (en) | 2007-03-15 |
| PE20070010A1 (es) | 2007-01-12 |
| BRPI0611491A2 (pt) | 2010-12-21 |
| EP1885358A2 (en) | 2008-02-13 |
| AR054467A1 (es) | 2007-06-27 |
| TW200716104A (en) | 2007-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010345A (es) | Inhibidores de beta-lactamasa | |
| CO2021006075A2 (es) | Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad de nlrp | |
| DOP2014000212A (es) | Compuestos inhibidores de beta-lactamasas | |
| CU20120071A7 (es) | DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA | |
| BR112015013123A2 (pt) | inibidores de beta-lactamase | |
| CR20110257A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes | |
| CR20120510A (es) | Derivados de piperidin-4-il azetidina como inhibidores de jak1 | |
| CO2017013360A2 (es) | Inhibidores de metalo-beta-lactamasa | |
| UY33476A (es) | Estimuladores de sgc | |
| GT200900146A (es) | Inhibidores de la actividad de la akt | |
| MX2019009853A (es) | Terapia de combinacion que incluye un inhibidor mdm2 y uno o mas agentes farmaceuticamente activos adicionales para el tratamiento de canceres. | |
| CO6440551A2 (es) | Compuestos pirazolo[1,5-a]pirimidina sustituida como inhibidores de trk cinasa | |
| BR112015018783A8 (pt) | misturas íntimas secas, composição, método para preparação de uma mistura íntima seca e método para aumentar a germinação, crescimento, metabolismo e/ou atividade enzimática de esporos bacterianos | |
| PE20160200A1 (es) | Inhibidores de bromodominios | |
| AR098960A1 (es) | Composiciones para el cuidado oral, prebióticas, que contienen aminoácidos, métodos, usos | |
| UY36749A (es) | Compuestos de aminopiridina sustituida con heteroarilo como inhibidores de quinasa y moduladores de irak-4, y composiciones farmacéuticas que los contienen | |
| ECSP088676A (es) | Pirazolquinolonas como potentes inhibidores de parp | |
| MX2016003486A (es) | Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades. | |
| UY36747A (es) | Compuestos de aminopiridina sustituida con heteroarilo como inhibidores de quinasa y modulantes de irak-4 y composiciones farmacéuticas que los contienen | |
| AR087847A1 (es) | Composiciones detergentes que comprenden enzima y tensioactivo | |
| CU20100170A7 (es) | Inhibidores heterocíclicos de estearoil-coa-desaturasa | |
| CO6480927A2 (es) | Derivados de imidazolin-2-ona 1,3-disustituida como inhibidores de cyp17. | |
| ZA202006612B (en) | Antibacterial compounds | |
| MX2015008029A (es) | Heterociclos n-acetilados y de nitrogeno saturados que potencian la actividad de un antibiotico activo contra micobacterias. | |
| GT201300041A (es) | Composicion fungicida sinergista |